BSX · 8-K · 20260518PR000042

Capital Return Program

BOSTON SCIENTIFIC CORP · 2026-05-18 · Importance 54 · Surprise 42 · In source text

Boston Scientific entered into a $2 billion accelerated share repurchase agreement with JPMorgan Chase as part of its previously authorized $5 billion common-stock repurchase program. The company will initially receive shares valued at 80% of the repurchase price, representing approximately 30.4 million shares based on the May 15, 2026 closing price of $52.68. Final shares repurchased will be determined using the volume-weighted average share price during the ASR term, less a discount, with final settlement expected by June 30, 2026. Following the ASR, $3 billion will remain available under the authorization, and the transaction is expected to increase full-year 2026 adjusted EPS by $0.02 relative to prior guidance.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashnegativecommitted—On May 18, 2026 Boston Scientific Corporation announced it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan…